Kangwei Xu

2.0k total citations
24 papers, 255 citations indexed

About

Kangwei Xu is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kangwei Xu has authored 24 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Infectious Diseases and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kangwei Xu's work include Influenza Virus Research Studies (9 papers), Respiratory viral infections research (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kangwei Xu is often cited by papers focused on Influenza Virus Research Studies (9 papers), Respiratory viral infections research (8 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Kangwei Xu collaborates with scholars based in China, Canada and Saudi Arabia. Kangwei Xu's co-authors include Junzhi Wang, Changgui Li, Anwar M. Hashem, Runtao He, Xuguang Li, Caroline Gravel, Michel Girard, Yves Aubin, Aaron Farnsworth and Wenbo Wang and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Hydrogen Energy.

In The Last Decade

Kangwei Xu

21 papers receiving 245 citations

Peers

Countries citing papers authored by Kangwei Xu

Since Specialization

Citations

This map shows the geographic impact of Kangwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kangwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kangwei Xu more than expected).

Fields of papers citing papers by Kangwei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kangwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kangwei Xu. The network helps show where Kangwei Xu may publish in the future.

Co-authorship network of co-authors of Kangwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kangwei Xu. A scholar is included among the top collaborators of Kangwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kangwei Xu. Kangwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Manganese (Ⅱ)-genistein complex as an efficient radical scavenger for fuel cells and investigation of its antioxidation mechanism 2025 ·International Journal of Hydrogen Energy ·Zhihui Wang, Kangwei Xu, Xiaojun Xu, (unknown), (unknown), Feng Liu, Yongming Zhang, Gang Wei, Supeng Pei	2
2	A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine 2025 ·Frontiers in Immunology ·Zihan Wang, (unknown), Xin Tang, (unknown), Ting‐Ting Wu, (unknown), (unknown), Weiheng Su, Chunlai Jiang, Yang Zang, Yaru Quan, Kangwei Xu, Bo Sun	0
3	Enhancing the Protein Stability of an Anticancer VHH‐Fc Heavy Chain Antibody through Computational Modeling and Variant Design 2025 ·Advanced Science ·Yuan Fang, (unknown), (unknown), Xiaoqing Song, Kangwei Xu, Pengcheng Shen, Ting Cao, (unknown), Simon Hsu, Dongmei Han, Qiang Huang	0
4	Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model 2024 ·Vaccines ·Yaru Quan, Chunxia Liu, Lu Xu, (unknown), Shuai Yang, (unknown), (unknown), (unknown), Kangwei Xu, Ling Peng	1
5	The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice 2024 ·Vaccines ·Kangwei Xu, Jing Li, Lu Xu, (unknown), (unknown), Jiahao Wang, (unknown), Yaru Quan, Changgui Li	1
6	CeO₂ stabilized by tourmaline as a novel inorganic filler to simultaneously increase the conductivity and durability of proton exchange membranes 2023 ·Inorganic Chemistry Frontiers ·Supeng Pei, Kangwei Xu, Xiaojun Xu, Guipeng Liu, (unknown), Yingge Zhang, Yecheng Zou, Feng Liu, Yongming Zhang, Yongfeng Zhou	4
7	The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS 2023 ·Vaccines ·Kangwei Xu, (unknown), (unknown), Yaru Quan, (unknown), Yaling Hu, Changgui Li	1
8	The impact of ambient air pollution on an influenza model with partial immunity and vaccination 2023 ·Mathematical Biosciences & Engineering ·Xiaomeng Wang, Xue Wang, (unknown), (unknown), Kangwei Xu, Qiang Gao, Rong Cai, Yongli Cai	1
9	Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine 2022 ·Vaccine ·Fan Gao, Chaoqiang An, Lianlian Bian, Yiping Wang, Jialu Zhang, (unknown), Qian He, (unknown), Lifang Song, (unknown), (unknown), Kangwei Xu, Changgui Li, Shanshan Yao, Wu Xing, Qunying Mao, Zhenglun Liang, Miao Xu	4
10	Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: A randomized, double-blind, controlled phase III study in healthy population aged ≥3 years 2020 ·Vaccine ·Kai Chu, Kangwei Xu, Rong Tang, Xiaohui Tian, Jialei Hu, (unknown), Changgui Li, Yuemei Hu, Gang Zeng	11
11	Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China 2019 ·Open Forum Infectious Diseases ·Yuemei Hu, Kangwei Xu, Weixiao Han, Kai Chu, Deyu Jiang, Jianfeng Wang, Xiaohui Tian, (unknown), Ying Zhang, Changgui Li, Fengcai Zhu	8
12	Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines 2018 ·Scientific Reports ·Kangwei Xu, Changgui Li, Caroline Gravel, Zheng Jiang, (unknown), Gary Van Domselaar, Xuguang Li, Junzhi Wang	6
13	A neuraminidase activity-based microneutralization assay for evaluating antibody responses to influenza H5 and H7 vaccines 2018 ·PLoS ONE ·Hui Zhao, Kangwei Xu, Zheng Jiang, Ming Shao, Shuzhen Liu, Xuguang Li, Junzhi Wang, Changgui Li	4
14	A simple and safe antibody neutralization assay based on polio pseudoviruses 2018 ·Human Vaccines & Immunotherapeutics ·Zheng Jiang, (unknown), Guoyang Liao, Mingbo Sun, Kangwei Xu, (unknown), Jianfeng Wang, Xuguang Li, Changgui Li	6
15	Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines 2015 ·Vaccine ·Caroline Gravel, (unknown), (unknown), Anwar M. Hashem, (unknown), Kangwei Xu, (unknown), (unknown), Aaron Farnsworth, Aline Rinfret, Gary Van Domselaar, Junzhi Wang, Changgui Li, Xuguang Li	8
16	Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine 2015 ·Human Vaccines & Immunotherapeutics ·Changgui Li, Kangwei Xu, Anwar M. Hashem, Ming Shao, Shuzhen Liu, Yong Zou, Qiang Gao, Yongchao Zhang, (unknown), Miao Xu, Xuguang Li, Junzhi Wang	9
17	Rapid preparation of antiserum against influenza virus (H7N9) hemagglutinin for single radial immunodiffusion assay 2014 ·Zhonghua weishengwuxue he mianyixue zazhi ·Kangwei Xu, Ming Shao, Shuzhen Liu, Fang Cai, Qiang Gao, Changgui Li, Junzhi Wang	3
18	Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes 2014 ·Mucosal Immunology ·Xinyu Fan, Anwar M. Hashem, (unknown), (unknown), Tracey M. Doyle, (unknown), (unknown), Aaron Farnsworth, Kangwei Xu, (unknown), Runtao He, (unknown), Junzhi Wang	35
19	A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification 2013 ·PLoS ONE ·Anwar M. Hashem, Caroline Gravel, Aaron Farnsworth, Wei Zou, (unknown), Kangwei Xu, Changgui Li, Junzhi Wang, (unknown), (unknown), Runtao He, Michel Gilbert, Xuguang Li	22
20	Antibodies to lipoarabinomannan antigen in sooty mangabey monkeys experimentally inoculated with Mycobacterium leprae. 1990 ·PubMed ·B J Gormus, Kangwei Xu, Wayne M. Meyers, G P Walsh, William R. Levis, Harry C. Meeker	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact